RUNX2 enhances bladder cancer progression by promoting glutamine metabolism
Bladder cancer is a prevalent malignancy within the urinary system. Prior research has suggested that glutamine metabolism plays a crucial role in driving bladder cancer progression. However, the precise molecular mechanism governing glutamine metabolism in bladder cancer is still inadequately under...
Saved in:
Main Authors: | Zhigang Huang, Bin Liu, Xiaoju Li, Chenghua Jin, Quansen Hu, Zhiwei Zhao, Yimin Sun, Qian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558624001611 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
by: Ding Nan, et al.
Published: (2025-01-01) -
Microenvironmental G protein‐coupled estrogen receptor‐mediated glutamine metabolic coupling between cancer‐associated fibroblasts and triple‐negative breast cancer cells governs tumour progression
by: Chongwu He, et al.
Published: (2024-12-01) -
PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men
by: Siresha Bathina, et al.
Published: (2025-01-01) -
Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer
by: Jingyang Li, et al.
Published: (2025-02-01) -
Custom exome panel revealed new mutations in MAPK14 and novel mutation in RUNX2 gene in patients with PCOS
by: Yunus Arikan, et al.
Published: (2025-01-01)